Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

February 11, 2019

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation CCVVC 2016

The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions

Presenter: Chris Metzger

June 15, 2016

Presentation

Drug-Coated Balloon for Revascularization of Infrapopliteal Arteries

Presenter: Salvatore Cassese

April 28, 2016

Presentation

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

Presenter: Thomas Zeller

October 23, 2015

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Presentation CICT 2015

Drug Eluting Femoral Stents Where does it fit in my practice?

Presenter: Yazan Khatib

July 31, 2015

Presentation CCVVC 2015

Covered Stents in Femoropopliteal Disease

Presenter: Subhash Banerjee

June 18, 2015

Presentation CCVVC 2015

CFA: Endo or Open

Presenter: Carlos I. Mena

June 18, 2015

Presentation CCVVC 2015

Economics of Drug-Coated Technology in PAD

Presenter: Mark W. Burket

June 17, 2015

Presentation ARCH 2015

Below the Knee Stenting

Presenter: George S. Chrysant

April 10, 2015

Presentation

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

Presenter: G.Tepe

February 04, 2015

Presentation ISET 2015

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Presenter: Gunnar Tepe

February 02, 2015

Presentation

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Presenter: Monika Herten

October 16, 2014

Presentation

Drug-Eluting Balloon in Peripheral Intervention for Below-the-Knee Angioplasty Evaluation

Presenter: Francesco Liistro

July 01, 2013

Presentation

Meta-analysis: Outcomes of Endovascular Treatment of Infrapopliteal Occlusive Disease with DES

Presenter: George A. Antoniou

May 02, 2013

Presentation

Single-Center Experience with DES for Treatment of Infrapopliteal Occlusive Disease in Patients with CLI: Midterm Follow-up

Presenter: Robert A. Lookstein

April 15, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Advertisement

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions

Drug-Coated Balloon for Revascularization of Infrapopliteal Arteries

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Drug Eluting Femoral Stents Where does it fit in my practice?

Covered Stents in Femoropopliteal Disease

CFA: Endo or Open

Economics of Drug-Coated Technology in PAD

Below the Knee Stenting

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Drug-Eluting Balloon in Peripheral Intervention for Below-the-Knee Angioplasty Evaluation

Meta-analysis: Outcomes of Endovascular Treatment of Infrapopliteal Occlusive Disease with DES

Single-Center Experience with DES for Treatment of Infrapopliteal Occlusive Disease in Patients with CLI: Midterm Follow-up

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content